In the BioHarmony Drug Report Database
Primidone
Mysoline (primidone) is a small molecule pharmaceutical. Primidone was first approved as Mysoline on 1982-01-01. It is used to treat epilepsy, partial epilepsies, tonic-clonic epilepsy, and tremor in the USA. It is known to target transient receptor potential cation channel subfamily M member 3.
Trade Name
|
Mysoline |
|---|---|
Common Name
|
primidone |
ChEMBL ID
|
CHEMBL856 |
Indication
|
epilepsy, partial epilepsies, tonic-clonic epilepsy, tremor |
Drug Class
|
Anticonvulsant, barbiturate |
Image (chem structure or protein)